Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Zack's Take on LMNL's Upcoming Q4 2020 Report
View:
Post by riskybznz on Mar 12, 2021 8:13pm

Zack's Take on LMNL's Upcoming Q4 2020 Report

Liminal BioSciences Inc. (LMNL) May Report Negative Earnings: Know the Trend Ahead of Q4 Release


Liminal BioSciences Inc. (LMNL) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2020. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. ......[Continues]

https://ca.finance.yahoo.com/news/liminal-biosciences-inc-lmnl-may-173005022.html
Comment by Newcamo on Mar 13, 2021 8:11am
This post has been removed in accordance with Community Policy
Comment by PLITheOne on Mar 13, 2021 8:57am
To accurately know where this is going all that you need to do is look at the ethics of these owners. They hide information and extract any potential out the back door. The steal from investors using loopholes in the current regulations. They will purposely devalue this company until they can take this technology private. Remember SALP retained the patents by leaving 10m loan on the books when it ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities